Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Tesla reports Q3 2026 results on Tuesday with the stock at $354.72, down 7.3% on the week and notably softer than the $375.23 level captured in Wednesday's trader note, and the options market has shifted decisively more bullish even as the price retreats.
The options picture is the sharpest change from the last two notes. The put/call ratio has dropped to 0.76, nearly two and a half standard deviations below its 20-day mean of 0.79. That is the most call-skewed reading in the past year, sitting close to the 52-week low of 0.68. Buyers are reaching for upside exposure, not hedging downside, an unusual posture for a stock that fell 15.6% on the day after its July print and dropped a further 21.3% over the following five sessions. On the short side, positioning is unremarkable. SI % FF has settled back to 2.10% after the mid-week rebuild and partial unwind described in prior notes. Borrow costs at 0.37% have fallen 26% on the week, and availability is completely unconstrained. There is no lending-market pressure in either direction.
The bull and bear cases are almost entirely about what comes next rather than what Q3 delivered. Bulls point to stronger-than-expected Q3 deliveries of 486,532 vehicles, trailing twelve-month sales crossing $103.62 billion, and $43.52 billion in cash plus $30 billion in new financing capacity. The FSD subscription pipeline, Cybercab, and Optimus are the valuation pillars for this camp, with Tigress Financial holding a $550 target and StoneX at $475. Bears counter with Q2's $0.33 EPS miss, $1.1 billion of negative free cash flow in that quarter, and a forward earnings multiple that remains punishing: the trailing PE is running at 170 times with EV/EBITDA near 78. Jefferies raised its target to $400 this week, and UBS moved its Neutral target to $391, both still above the current price. Goldman Sachs held its Neutral stance at $360. JPMorgan cut its target in late September to $415 from $445, still reflecting Street unease about capital efficiency. The analyst consensus mean target is $397.83, implying modest upside from here, but GLJ Research's persistent Sell at $24.86 is a reminder of how wide the distribution of views remains on this stock.
The one piece of differentiated external data points firmly in the bulls' direction. KBA German new car registrations, the only European dataset ORTEX has measured to lead Tesla's quarterly revenue, with a strong fit over 18 quarters and a 100% directional hit rate, show Tesla registrations in Germany running 269% above the same quarter last year. The full quarter is in: all three months from July through September are captured in the reading of 15,953 vehicles. That is the complete data window for Q3. The KBA series leads revenue by 43 days, placing this reading squarely ahead of the Tuesday print.
The earnings report on Tuesday is therefore less a delivery story, those numbers are largely known, and more a test of whether Tesla's margin trajectory and guidance on FSD commercialisation, Cybercab timing, and Optimus production can justify a multiple that still prices in transformational outcomes despite a stock now sitting nearly 8% lower than it was 72 hours ago.
See the live data behind this article on ORTEX.
Open TSLA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
